Clinical Trial: Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast Cancer

U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07389200) titled 'Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast Cancer' on Jan. 10.

Brief Summary: In addition to TNM staging, the current management of breast cancer is based on conventional pathological features that categorize the disease into three molecular subtypes, each with significant prognostic implications in clinical practice: human epidermal growth factor receptor 2 (HER2)-positive, luminal (hormone receptor-positive and HER2-negative), and triple-negative breast cancers. The overexpression or amplification of HER2 is observed in 10-15% of breast cancer cases. This phenomenon oft...